[go: up one dir, main page]

MX2019004611A - Metodos y composiciones para cambiar la composicion del microbioma de la piel usando mezclas complejas de cepas bacterianas. - Google Patents

Metodos y composiciones para cambiar la composicion del microbioma de la piel usando mezclas complejas de cepas bacterianas.

Info

Publication number
MX2019004611A
MX2019004611A MX2019004611A MX2019004611A MX2019004611A MX 2019004611 A MX2019004611 A MX 2019004611A MX 2019004611 A MX2019004611 A MX 2019004611A MX 2019004611 A MX2019004611 A MX 2019004611A MX 2019004611 A MX2019004611 A MX 2019004611A
Authority
MX
Mexico
Prior art keywords
bacterial strains
compositions
methods
changing
composition
Prior art date
Application number
MX2019004611A
Other languages
English (en)
Inventor
Pätzold Bernhard
Güell Marc
Original Assignee
S Biomedic Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S Biomedic Nv filed Critical S Biomedic Nv
Publication of MX2019004611A publication Critical patent/MX2019004611A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Los aspectos de la invencion se refieren a composiciones que comprenden dos o mas cepas bacterianas vivas para administracion topica en la piel, en las que las dos o mas cepas bacterianas vivas son cepas bacterianas de Propionibacterium acnes (P. acnes) y metodos para su uso.
MX2019004611A 2016-10-19 2017-10-19 Metodos y composiciones para cambiar la composicion del microbioma de la piel usando mezclas complejas de cepas bacterianas. MX2019004611A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662410329P 2016-10-19 2016-10-19
US201762536761P 2017-07-25 2017-07-25
PCT/IB2017/001481 WO2018073651A1 (en) 2016-10-19 2017-10-19 Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains

Publications (1)

Publication Number Publication Date
MX2019004611A true MX2019004611A (es) 2019-09-18

Family

ID=61054421

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019004611A MX2019004611A (es) 2016-10-19 2017-10-19 Metodos y composiciones para cambiar la composicion del microbioma de la piel usando mezclas complejas de cepas bacterianas.

Country Status (11)

Country Link
US (1) US11541081B2 (es)
EP (2) EP3912630B1 (es)
JP (1) JP7235654B2 (es)
KR (1) KR102584057B1 (es)
CN (1) CN110352065A (es)
CA (1) CA3040814A1 (es)
DK (1) DK3528825T3 (es)
ES (2) ES2967029T3 (es)
MX (1) MX2019004611A (es)
PL (2) PL3912630T3 (es)
WO (1) WO2018073651A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201405783VA (en) * 2012-03-17 2014-10-30 Univ California Fast diagnosis and personalized treatments for acne
EP3285872A4 (en) 2015-04-20 2019-02-20 S-Biomedic NV METHOD AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF SKIN MICROBIOMA WITH COMPLEX MIXTURES OF BACTERIAL BARS
WO2018073651A1 (en) * 2016-10-19 2018-04-26 S-Biomedic Nv Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
EP3593267A4 (en) * 2017-03-10 2020-12-30 Prodermiq, Inc. SKIN CARE PRODUCTS AND PERSONAL CARE PRODUCTS CUSTOMIZED BY SKIN FLORA ANALYSIS
US12502350B2 (en) 2018-06-14 2025-12-23 Beiersdorf Ag Cosmetic preparation against acne
WO2020099663A1 (en) 2018-11-16 2020-05-22 S-biomedic N.v. Compositions for treating oxidative stress-associated skin diseases and skin ageing and diagnosis of oxidative stress-associated skin diseases
CN114901246A (zh) * 2019-10-03 2022-08-12 S-生物医药有限公司 新的皮肤护理组合物
US20220354776A1 (en) * 2019-10-03 2022-11-10 Beiersdorf Ag Novel skin care composition
MX2022004054A (es) 2019-10-03 2022-05-02 S Biomedic Composicion novedosa para el cuidado de la piel.
CN114901242A (zh) 2019-10-03 2022-08-12 S-生物医药有限公司 新的皮肤护理组合物
CN114929196A (zh) * 2019-10-03 2022-08-19 S-生物医药有限公司 新的皮肤护理组合物
EP4037769A1 (en) 2019-10-03 2022-08-10 S-Biomedic Novel skin care composition
US20220395451A1 (en) * 2019-10-03 2022-12-15 Beiersdorf Ag Novel skin care composition
CN110846375B (zh) * 2019-10-23 2023-05-05 深圳艾尔生物科技有限公司 一种用于细菌电阻计数的培养基组合物、制备方法及其应用
US11197824B2 (en) * 2020-01-16 2021-12-14 David Changaris Solution and method for reducing the virulence of viruses, bacteria,yeasts, or fungus
EP4197523A1 (en) 2021-12-17 2023-06-21 DSM IP Assets B.V. A freeze-dried composition and preparation thereof
EP4447924A1 (en) 2021-12-17 2024-10-23 S-Biomedic A freeze-dried composition and preparation thereof
WO2023135186A1 (en) 2022-01-12 2023-07-20 S-Biomedic Nv Skin care composition and uses thereof

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2101263T3 (es) 1993-02-19 1997-07-01 Howard Green Composiciones que contienen proteinas de corneocitos.
KR960700684A (ko) 1993-12-15 1996-02-24 노부찌까 우라까베 화장용 조성물(cosmetic)
US6743609B1 (en) 1997-12-23 2004-06-01 Arkion Life Sciences Llc Linoleate isomerase
US6821770B1 (en) 1999-05-03 2004-11-23 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US6794537B1 (en) 2002-11-07 2004-09-21 Sami Labs Limited Manufacturing processes for Se-methyl-L-selenocysteine
CA2612408A1 (en) 2005-06-15 2006-12-28 Apollo Pharmaceutical, Inc. Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis
EP2184997A4 (en) 2007-07-31 2010-11-03 Univ New York DIAGNOSIS AND TREATMENT METHODS FOR THE CHARACTERIZATION OF BACTERIAL MICROORGANISMS IN SKIN DISEASES
BRPI0916690B1 (pt) 2008-07-29 2022-04-12 L'oreal Uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição coméstica e/ou dermatólogica, método coméstico para tratar e/ou prevenir distúrbios estéticos do couro cabeludo em um indivíduo, processo cosmético para prevenir e/ou tratar uma condição de caspa do couro cabeludo, conjunto cosmético, e, uso cosmético de pelo menos uma quantidade eficaz de pelo menos um primeiro e um segundo agente cosmético ativo
WO2010080543A1 (en) 2008-12-18 2010-07-15 Guthery B Eugene Acne vulgaris treatment regimen
US20100260695A1 (en) 2009-04-09 2010-10-14 Mary Kay Inc. Combination of plant extracts to improve skin tone
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
ITPR20110035A1 (it) 2011-05-06 2012-11-07 Bormioli Rocco & Figlio Spa Capsula.
WO2013067185A1 (en) 2011-11-02 2013-05-10 Bios Llc Probiotic stick formulation for skin maintenance and methods of use
SG11201405783VA (en) 2012-03-17 2014-10-30 Univ California Fast diagnosis and personalized treatments for acne
HUE040211T2 (hu) 2013-06-05 2019-02-28 Rebiotix Inc Mikrobióta-helyreállítási terápia (MRT), készítmények és elõállítási eljárások
US20150037285A1 (en) 2013-07-03 2015-02-05 New York University Methods for efficient transfer of viable and bioactive microbiota
US20150050245A1 (en) 2013-08-14 2015-02-19 Tntgamble, Inc. Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora
EP3132021B1 (en) * 2014-04-15 2023-03-08 Aobiome LLC Ammonia-oxidizing nitrosomonas eutropha strain d23
US20170065647A1 (en) 2014-05-07 2017-03-09 The Regents Of The University Of California Compositions and methods for treating skin and mucous membrane diseases
SI3158054T1 (sl) 2014-06-17 2025-06-30 Crown Laboratories, Inc. Genetsko modificirane bakterije in postopki za genetsko modifikacijo bakterij
EP3285872A4 (en) * 2015-04-20 2019-02-20 S-Biomedic NV METHOD AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF SKIN MICROBIOMA WITH COMPLEX MIXTURES OF BACTERIAL BARS
CN105168077A (zh) * 2015-08-14 2015-12-23 无限极（中国）有限公司 一种皮肤护理组合物及其应用、制备方法、产品
WO2017044835A1 (en) 2015-09-10 2017-03-16 Xycrobe Therapeutics, Inc. Genetically modified bacteria, compositions and methods of making and using
EP3411011B1 (en) 2016-02-05 2024-09-18 The Regents of the University of California Compositions and methods for promoting skin health
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
ITUA20162141A1 (it) 2016-03-31 2017-10-01 Bormioli Pharma Spa Capsula di chiusura
WO2017185016A1 (en) 2016-04-21 2017-10-26 Naked Biome, Inc. Skin disorder therapeutics and methods of use
CN109715179A (zh) 2016-04-21 2019-05-03 内科德生物群系公司 用于治疗皮肤病症的组合物和方法
EP3445844A4 (en) 2016-04-21 2019-11-13 Naked Biome, Inc. SYNTHETIC BACTERIA AND METHODS OF USE
IT201600097495A1 (it) 2016-09-28 2018-03-28 Bormioli Pharma S R L Capsula con struttura di contenimento e rilascio di un prodotto
WO2018073651A1 (en) * 2016-10-19 2018-04-26 S-Biomedic Nv Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
EP3630058A4 (en) 2017-05-22 2021-03-24 Dermala Inc. COMPOSITIONS AND PROCEDURES TO PREVENT, DECELERATE AND REVERSE SKIN AGING
US12502350B2 (en) 2018-06-14 2025-12-23 Beiersdorf Ag Cosmetic preparation against acne
WO2020099663A1 (en) 2018-11-16 2020-05-22 S-biomedic N.v. Compositions for treating oxidative stress-associated skin diseases and skin ageing and diagnosis of oxidative stress-associated skin diseases
CN114929196A (zh) 2019-10-03 2022-08-19 S-生物医药有限公司 新的皮肤护理组合物
CN114901242A (zh) 2019-10-03 2022-08-12 S-生物医药有限公司 新的皮肤护理组合物
US20220354776A1 (en) 2019-10-03 2022-11-10 Beiersdorf Ag Novel skin care composition
EP4037769A1 (en) 2019-10-03 2022-08-10 S-Biomedic Novel skin care composition
US20220395451A1 (en) 2019-10-03 2022-12-15 Beiersdorf Ag Novel skin care composition
CN114901246A (zh) 2019-10-03 2022-08-12 S-生物医药有限公司 新的皮肤护理组合物
MX2022004054A (es) 2019-10-03 2022-05-02 S Biomedic Composicion novedosa para el cuidado de la piel.

Also Published As

Publication number Publication date
EP3528825B1 (en) 2021-07-14
ES2967029T3 (es) 2024-04-25
WO2018073651A1 (en) 2018-04-26
JP2019535681A (ja) 2019-12-12
DK3528825T3 (da) 2021-08-30
EP3912630B1 (en) 2023-10-11
US20190314428A1 (en) 2019-10-17
CA3040814A1 (en) 2018-04-26
PL3528825T3 (pl) 2022-01-31
KR20190084988A (ko) 2019-07-17
KR102584057B1 (ko) 2023-09-27
CN110352065A (zh) 2019-10-18
EP3912630C0 (en) 2023-10-11
EP3912630A1 (en) 2021-11-24
EP3528825A1 (en) 2019-08-28
US11541081B2 (en) 2023-01-03
PL3912630T3 (pl) 2024-04-15
US20210187043A9 (en) 2021-06-24
JP7235654B2 (ja) 2023-03-08
ES2894498T3 (es) 2022-02-14

Similar Documents

Publication Publication Date Title
MX2019004611A (es) Metodos y composiciones para cambiar la composicion del microbioma de la piel usando mezclas complejas de cepas bacterianas.
ZA202004557B (en) Modulatory polynucleotides
MX2023010042A (es) Polinucleotidos moduladores.
PH12018500714A1 (en) Anti-tigit antigen-binding proteins and methods of use thereof
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
PH12019501405A1 (en) Anti-neuropilin antigen-binding proteins and methods of use thereof
EP4620519A3 (en) Methods and compositions relating to chondrisomes from blood products
EA201891083A1 (ru) Составы антител к cd38 для подкожного введения и их применение
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
AU2017228405A8 (en) Small molecule IRE1-alpha inhibitors
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
EA201692422A1 (ru) Состав, содержащий пролекарство гемцитабина
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
WO2017083431A3 (en) Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
MX2019010440A (es) Proteinas de union a antigeno anti-tigit y metodos de uso de las mismas.
EP4480544A3 (en) Immunomodulatory compositions andmethods of use thereof
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2019004580A (es) Formulaciones farmaceuticas y metodos para prepararlas.
MX2019005821A (es) Proteínas de unión a antígenos anti-gitr y métodos de uso de las mismas.
MX368268B (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
MX2018014790A (es) Formulacion combinada de tres compuestos antivirales.